Rachela Popovtzer

This inventor holds 6 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Bar-Ilan University, Tel Aviv University, Ariel Scientific Innovations Ltd.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachela Popovtzer. Retrieved from https://idiyas.com/inventor/rachela-popovtzer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 4)

% Patents Active = 66.7

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Ariel Scientific Innovations Ltd.

patents

4. 1 out of 1

Nanocarry Therapetics Ltd.

patent

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569569 - Nano-delivery system and therapeutic and diagnostic use thereof (2026-03-10),

2. 12226496 - Polymeric core-shell particles (2025-02-18),

3. 10478132 - Glucose conjugated gold nanoparticle (2019-11-19),

4. 10421785 - Delta receptor agonist peptides and use thereof (2019-09-24),

5. 8530179 - Electrochemical methods of detecting cancer with 4-aminophenyl phosphate (2013-09-10),

6. 8268577 - Electrochemical methods of detecting colon cancer cells and use of same for diagnosing and monitoring treatment of the disease (2012-09-18),

Title: Innovator Spotlight: Rachela Popovtzer

Introduction: Rachela Popovtzer, a talented inventor hailing from Givat Shmuel, IL, has made significant contributions in the field of medical technology and pharmaceuticals. With a total of 4 patents to her name, Rachela's innovative spirit and dedication to improving healthcare have led to groundbreaking advancements in diagnosing and treating various medical conditions.

Latest Patents: Among Rachela Popovtzer's latest patents is the "Glucose Conjugated Gold Nanoparticle - Composition Methods and Kits for Diagnosing and Treating Tumors Within a Subject." This patent details compositions involving gold nanoparticles, PEG derivatives, and 2-Deoxy-D-glucose, aimed at diagnosing and treating tumors in patients effectively.

Another notable patent is the "Delta Receptor Agonist Peptides and Use Thereof," which focuses on peptides functioning as delta opioid receptor agonists. These peptides, along with specific compositions, target medical conditions such as pain management and reducing cravings associated with substances like cocaine.

Career Highlights: Rachela Popovtzer has left her mark on renowned institutions such as Ramot at Tel Aviv University Ltd. and Bar-Ilan University. Her innovative work in these esteemed organizations has not only garnered recognition but has also propelled advancements in the medical and pharmaceutical domains.

Collaborations: Throughout her career, Rachela has collaborated with esteemed professionals in the field, including Judith Rishpon and Yosi Shacham-Diamand. These collaborations have fostered a conducive environment for creative idea exchange and have resulted in impactful inventions that have the potential to revolutionize healthcare practices.

Conclusion: Rachela Popovtzer's journey as an inventor showcases her unwavering commitment to pioneering solutions that address critical medical needs. Through her patents and collaborations, she continues to push the boundaries of innovation, making significant strides in the realm of medical technology.

Profile summary based on public USPTO records.